Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Guidance for the Knowledge and Skills required for Antimicrobial Stewardship Leaders: an update from the Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Use of Procalcitonin as a Tool to Enhance Antimicrobial Stewardship.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial.

EClinicalMedicine·2025
Same author

Pulmonary Infections in Adults: Community-Acquired Pneumonia.

FP essentials·2025
Same author

Pulmonary Infections in Adults: Nosocomial Pneumonia.

FP essentials·2025
Same author

Pulmonary Infections in Adults: Pulmonary Infections in Immunocompromised Patients.

FP essentials·2025

相关实验视频

Updated: Jul 18, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

在社区获得的肺炎.

Thomas M File1

  • 1Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, and Infectious Disease Service, Summa Health System, Akron, Ohio, USA. filet@summa-health.org

Lancet (London, England)
|December 20, 2003
PubMed
概括

由于抗微生物药物耐药性和新的病原体数据,成年人的社区获得性肺炎 (CAP) 管理正在发展. 及时的抗生素,适当的药物选择和疫苗接种是改善患者结果的关键.

科学领域:

  • 传染性疾病 传染性疾病
  • 肺部病理学 肺部病理学
  • 临床微生物学 临床微生物学

背景情况:

  • 社区获得性肺炎 (CAP) 仍然是免疫能力强的成年人的重大健康问题.
  • 肺炎链球菌 (Streptococcus pneumoniae) 新出现的抗微生物耐药性影响了实证治疗策略.
  • 鉴定非典型病原体需要进一步研究它们的临床意义.

研究的目的:

  • 审查有关CAP病因,临床过程,诊断,治疗和预防的当前信息.
  • 突出与免疫能力强的成年人相关的管理问题.
  • 讨论最近关于农业政策管理的指导方针建议.

主要方法:

  • 审查当前的文献和最近的指南出版物关于社区获得的肺炎.
  • 分析致病原体的新兴趋势,诊断方法和治疗策略.
  • 讨论影响临床结果和预防方法的因素.

主要成果:

  • 肺炎链球菌是主要的病原体,但耐药性正在增加.
  • 不典型的病原体经常被确定,尽管由于诊断的局限性,它们的临床影响往往不清楚.
  • 经验性抗微生物治疗仍然是标准的,以病原体谱和药理动力学/药理动力学原则为指导.

更多相关视频

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification
06:11

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification

Published on: March 29, 2024

相关实验视频

Last Updated: Jul 18, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification
06:11

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification

Published on: March 29, 2024

结论:

  • 及时使用抗微生物药物,适当选择抗生素,并遵守临床途径,改善了CAP的结果.
  • 对肺炎球菌病和流感的疫苗接种对于预防至关重要.
  • 更新的指南为免疫能力强的成年人管理CAP提供了有价值的建议.